{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T17:45:27Z","timestamp":1790963127983,"version":"4.1.0"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T00:00:00Z","timestamp":1685404800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Humans with hypertensive heart disease are more likely to experience heart failure, arrhythmia, myocardial infarction, and sudden death, and it is crucial to treat this condition. Fucoidan (FO) is a natural substance derived from marine algae that has antioxidant and immunomodulatory activities. FO has also been shown to regulate apoptosis. However, whether FO can protect against cardiac hypertrophy is unknown.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> We investigated the effect of FO in hypertrophic models <jats:italic>in vivo<\/jats:italic> and <jats:italic>in vitro<\/jats:italic>. C57BL\/6 mice were given an oral gavage of FO (300\u00a0mg\/kg\/day) or PBS (internal control) the day before surgery, followed by a 14-day infusion of Ang II or saline. AC-16 cells were treated with si-USP22 for 4\u00a0h and then treated with Ang II (100\u00a0nM) for 24\u00a0h. Systolic blood pressure (SBP) was recorded, echocardiography was used to assess cardiac function, and pathological changes in heart tissues were assessed by histological staining. Apoptosis levels were detected by TUNEL assays. The mRNA level of genes was assessed by qPCR. Protein expression was detected by immunoblotting.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> Our data showed that USP22 expression was lowered in Ang II-infused animals and cells, which could promote cardiac dysfunction and remodeling. However, treatment with FO significantly upregulated the expression of USP22 and reduced the incidence of cardiac hypertrophy, fibrosis, inflammation, and oxidative responses. Additionally, FO treatment lowered p53 expression and apoptosis while increasing Sirt 1 and Bcl-2 expression.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> By reducing the level of Ang II-induced apoptosis through the regulation of USP22\/Sirt 1 expression, FO treatment might improve cardiac function. According to this study, FO might be potential targeted approach for treating heart failure.<\/jats:p>","DOI":"10.3389\/fphar.2023.1164333","type":"journal-article","created":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T08:16:31Z","timestamp":1685434591000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Fucoidan inhibits apoptosis and improves cardiac remodeling by inhibiting p53 transcriptional activation through USP22\/Sirt 1"],"prefix":"10.3389","volume":"14","author":[{"given":"Shuai","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yilin","family":"Che","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weikun","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,5,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"5044046","DOI":"10.1155\/2022\/5044046","article-title":"Angiotensin II induces cardiac edema and hypertrophic remodeling through lymphatic-dependent mechanisms","volume":"2022","author":"Bai","year":"2022","journal-title":"Oxid. Med. Cell Longev."},{"key":"B2","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1002\/emmm.201000080","article-title":"Angiotensin II revisited: New roles in inflammation, immunology and aging","volume":"2","author":"Benigni","year":"2010","journal-title":"EMBO Mol. Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1291\/hypres.28.191","article-title":"Hypertensive heart disease","volume":"28","author":"Diamond","year":"2005","journal-title":"Hypertens. Res."},{"key":"B4","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.bbamcr.2013.06.027","article-title":"Regulation of proteolysis by human deubiquitinating enzymes","volume":"1843","author":"Eletr","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"B5","doi-asserted-by":"publisher","first-page":"571","DOI":"10.3390\/md17100571","article-title":"Therapies from fucoidan: New developments","volume":"17","author":"Fitton","year":"2019","journal-title":"Mar. Drugs"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1021361","DOI":"10.3389\/fphar.2022.1021361","article-title":"Administration of USP7 inhibitor P22077 inhibited cardiac hypertrophy and remodeling in Ang II-induced hypertensive mice","volume":"13","author":"Gu","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.phytochem.2013.12.003","article-title":"Alpha-amylase and alpha-glucosidase inhibition is differentially modulated by fucoidan obtained from Fucus vesiculosus and Ascophyllum nodosum","volume":"98","author":"Kim","year":"2014","journal-title":"Phytochemistry"},{"key":"B8","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3389\/fmolb.2020.00021","article-title":"Resolving the complexity of ubiquitin networks","volume":"7","author":"Kliza","year":"2020","journal-title":"Front. Mol. Biosci."},{"key":"B9","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/978-1-4419-6676-6_6","article-title":"Mechanism, specificity and structure of the deubiquitinases","volume":"54","author":"Komander","year":"2010","journal-title":"Subcell. Biochem."},{"key":"B10","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1146\/annurev-biochem-060310-170328","article-title":"The ubiquitin code","volume":"81","author":"Komander","year":"2012","journal-title":"Annu. Rev. Biochem."},{"key":"B11","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1002\/dmrr.539","article-title":"Salt and hypertension: A phylogenetic perspective","volume":"21","author":"Lev-Ran","year":"2005","journal-title":"Diabetes Metab. Res. Rev."},{"key":"B12","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1161\/HYPERTENSIONAHA.117.10390","article-title":"Novel role for the immunoproteasome subunit PSMB10 in angiotensin II-induced atrial fibrillation in mice","volume":"71","author":"Li","year":"2018","journal-title":"Hypertension"},{"key":"B13","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1161\/HYPERTENSIONAHA.118.11813","article-title":"Immunoproteasome subunit \u03b25i promotes Ang II (angiotensin II)-Induced atrial fibrillation by targeting ATRAP (Ang II type I receptor-associated protein) degradation in mice","volume":"73","author":"Li","year":"2019","journal-title":"Hypertension"},{"key":"B14","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1007\/s00018-008-8090-6","article-title":"Polyubiquitin chains: Functions, structures, and mechanisms","volume":"65","author":"Li","year":"2008","journal-title":"Cell Mol. Life Sci."},{"key":"B15","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.molcel.2012.03.024","article-title":"USP22 antagonizes p53 transcriptional activation by deubiquitinating Sirt1 to suppress cell apoptosis and is required for mouse embryonic development","volume":"46","author":"Lin","year":"2012","journal-title":"Mol. Cell"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.3390\/md9071273","article-title":"Bromophenols in marine algae and their bioactivities","volume":"9","author":"Liu","year":"2011","journal-title":"Mar. Drugs"},{"key":"B17","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.3892\/ijmm.2019.4125","article-title":"Sirt1 promotes autophagy and inhibits apoptosis to protect cardiomyocytes from hypoxic stress","volume":"43","author":"Luo","year":"2019","journal-title":"Int. J. Mol. Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"487","DOI":"10.3390\/md17090487","article-title":"Therapeutic effects of fucoidan: A review on recent studies","volume":"17","author":"Luthuli","year":"2019","journal-title":"Mar. Drugs"},{"key":"B19","doi-asserted-by":"publisher","first-page":"551318","DOI":"10.3389\/fphys.2020.551318","article-title":"USP22 protects against myocardial ischemia-reperfusion injury via the SIRT1-p53\/slc7a11-dependent inhibition of ferroptosis-induced cardiomyocyte death","volume":"11","author":"Ma","year":"2020","journal-title":"Front. Physiol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1038\/sj.ejcn.1602562","article-title":"Effects of consuming foods containing oat beta-glucan on blood pressure, carbohydrate metabolism and biomarkers of oxidative stress in men and women with elevated blood pressure","volume":"61","author":"Maki","year":"2007","journal-title":"Eur. J. Clin. Nutr."},{"key":"B21","doi-asserted-by":"publisher","first-page":"44848","DOI":"10.18632\/oncotarget.8602","article-title":"Ubiquitin-specific peptidase 22 functions and its involvement in disease","volume":"7","author":"Melo-Cardenas","year":"2016","journal-title":"Oncotarget"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1021\/jf000574n","article-title":"In vitro study of possible role of dietary fiber in lowering postprandial serum glucose","volume":"49","author":"Ou","year":"2001","journal-title":"J. Agric. Food Chem."},{"key":"B23","doi-asserted-by":"publisher","first-page":"275","DOI":"10.3390\/md18050275","article-title":"Mechanisms of bioactivities of fucoidan from the Brown seaweed fucus vesiculosus L. Of the barents sea","volume":"18","author":"Pozharitskaya","year":"2020","journal-title":"Mar. Drugs"},{"key":"B24","doi-asserted-by":"publisher","first-page":"132","DOI":"10.3390\/md16040132","article-title":"Pharmacokinetic and tissue distribution of fucoidan from fucus vesiculosus after oral administration to rats","volume":"16","author":"Pozharitskaya","year":"2018","journal-title":"Mar. Drugs"},{"key":"B25","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.yjmcc.2016.06.001","article-title":"Physiological and pathological cardiac hypertrophy","volume":"97","author":"Shimizu","year":"2016","journal-title":"J. Mol. Cell Cardiol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.hfc.2019.06.007","article-title":"Hypertension and heart failure","volume":"15","author":"Slivnick","year":"2019","journal-title":"Heart Fail Clin."},{"key":"B27","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1271\/bbb.90705","article-title":"Development of a fucoidan-specific antibody and measurement of fucoidan in serum and urine by sandwich ELISA","volume":"74","author":"Tokita","year":"2010","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1038\/s41419-021-04059-y","article-title":"Circ-SIRT1 inhibits cardiac hypertrophy via activating SIRT1 to promote autophagy","volume":"12","author":"Wang","year":"2021","journal-title":"Cell Death Dis."},{"key":"B29","doi-asserted-by":"publisher","first-page":"392","DOI":"10.3390\/md16100392","article-title":"Fucoidan inhibits radiation-induced pneumonitis and lung fibrosis by reducing inflammatory cytokine expression in lung tissues","volume":"16","author":"Yu","year":"2018","journal-title":"Mar. Drugs"},{"key":"B30","doi-asserted-by":"publisher","first-page":"3068","DOI":"10.3390\/nu12103068","article-title":"Oligo-fucoidan improves diabetes-induced renal fibrosis via activation of sirt-1, GLP-1R, and Nrf2\/HO-1: An in vitro and in vivo study","volume":"12","author":"Yu","year":"2020","journal-title":"Nutrients"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.3109\/13880209.2014.982298","article-title":"Cardioprotective effects of fucoidan against hypoxia-induced apoptosis in H9c2 cardiomyoblast cells","volume":"53","author":"Zhang","year":"2015","journal-title":"Pharm. Biol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"R143","DOI":"10.1530\/JME-16-0086","article-title":"The role of autophagy in angiotensin II-induced pathological cardiac hypertrophy","volume":"57","author":"Zhou","year":"2016","journal-title":"J. Mol. Endocrinol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1164333\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T08:51:07Z","timestamp":1685436667000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1164333\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,30]]},"references-count":32,"alternative-id":["10.3389\/fphar.2023.1164333"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2023.1164333","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,30]]},"article-number":"1164333"}}